MF59 ® -Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults

Angelika Banzhoff, Roberto Gasparini, Franco Laghi-Pasini et al. · 2009

Read MF59 ® -Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults by Angelika Banzhoff, Roberto Gasparini, Franco Laghi-Pasini et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004384.txt.

Description

The H5N1 bird flu virus raised fears of a human pandemic. A vaccine that trains lasting, broad immunity would be a strong defense. Angelika Banzhoff, Roberto Gasparini, Franco Laghi-Pasini, and co-authors tested such a vaccine in 2009. Their PLOS ONE paper covers adults in two age bands. One group was aged eighteen to sixty, the other over sixty.

The vaccine used an added booster ingredient called MF59. In total, 313 younger adults and 173 older adults took part. The authors report the shot built immune memory. It also raised antibodies that respond across differing strains, called heterotypic responses. Broad memory of that kind is what pandemic planners hope to bank ahead of time.

Catalog record

CREATORAngelika Banzhoff, Roberto Gasparini, Franco Laghi-Pasini et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004384

Browse the full library · About the Tower of Babel